AVI BIOPHARMA INC
10-Q, EX-27, 2000-08-09
PHARMACEUTICAL PREPARATIONS
Previous: AVI BIOPHARMA INC, 10-Q, 2000-08-09
Next: CARCO AUTO LOAN MASTER TRUST, 10-Q, 2000-08-09



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                       6,949,190
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            10,597,332
<PP&E>                                       3,141,532
<DEPRECIATION>                               2,589,611
<TOTAL-ASSETS>                              12,426,765
<CURRENT-LIABILITIES>                        1,104,596
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         1,675
<OTHER-SE>                                  10,592,494
<TOTAL-LIABILITY-AND-EQUITY>                12,426,765
<SALES>                                              0
<TOTAL-REVENUES>                             1,150,123
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             5,346,663
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (3,980,295)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (3,980,295)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (3,980,295)
<EPS-BASIC>                                     (0.24)
<EPS-DILUTED>                                   (0.24)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission